Episode
Who fact checks the fact checkers
- Podcast
- Dr. John Campbell
- Published
- Sep 6, 2026
- Duration seconds
- 1371
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/VG2890922216.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/who-fact-checks-the-fact-checkers/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-john-campbell-7851784/who-fact-checks-the-fact-checkers.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Now all of the facts were equal, but some facts were more equal than others. Institute for Scientific Freedom https://www.scientificfreedom.dk/strategy/?utm_source=substack&utm_medium=email 1 All science should strive to be free from financial conflicts of interest. 2 All science should be published as soon as possible and made freely accessible. 3 All scientific data, including study protocols, should be freely accessible, allowing others to do their own analyses. Open letter from BMJ to Facebook about inappropriate censoring of serious data integrity issues in Pfizer’s COVID-19 vaccine trial https://www.scientificfreedom.dk/2021/12/18/open-letter-from-bmj-to-facebook-about-inappropriate-censoring-of-serious-data-integrity-issues-in-pfizers-covid-19-vaccine-trial/ https://www.bmj.com/content/375/bmj.n2635/rr-80 Fiona Godlee, editor in chief Kamran Abbasi, incoming editor in chief The BMJ Competing interests: As current and incoming editors in chief, we are responsible for everything The BMJ contains. Dear Mark Zuckerberg, The BMJ, one of the world’s oldest and most influential general medical journals. https://www.bmj.com/about-bmj/history-of-the-bmj 3rd October 1840 Serious concerns about the “fact checking” being undertaken by third party providers on behalf of Facebook/Meta. In September, a former employee of Ventavia, a contract research company helping carry out the main Pfizer covid-19 vaccine trial, began providing The BMJ with dozens of internal company documents, photos, audio recordings, and emails. These materials revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety. We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA di…